A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
Clinical trial NCT00230698 · COMPLETED
Trial details
- NCT number
- NCT00230698
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-11-01
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.